UI-spinout Company Selected by National Cancer Institute's Business Accelerator Program

December 21, 2016

Viewpoint Molecular Targeting, founded with the support of UI Ventures, was selected by the National Cancer Institute (NCI) to be a part of the business accelerator program I-Corps in 2017.

UI Spinoff Immortagen Completes Series A Financing

September 6, 2016

Launched in 2014 by University of Iowa researchers, Immortagen is a company that is developing genetic analysis tools for personalized medicine. The company is led by John Pappajohn and is moving forward with multiple product platforms.